Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term inhibition. Found 53 abstracts

no pagination
Denlinger CS, Meropol NJ, Li T, Lewis NL, Engstrom PF, Weiner LM, Cheng JD, Alpaugh RK, Cooper H, Wright JJ, Cohen SJ. A Phase II Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Biliary Tract Cancers. Clinical Colorectal Cancer. 2014 Jun;13(2):81-6.   PMCID: Pmc4189831
Mu ZM, Li H, Fernandez SV, Alpaugh KR, Zhang RG, Cristofanilli M. EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells. Journal of Experimental & Clinical Cancer Research. 2013 Sep;32:70.   PMCID: PMC 3850122
Fu J, Bassi DE, Zhang JR, Li TY, Nicolas E, Klein-Szanto AJ. Transgenic Overexpression of the Proprotein Convertase Furin Enhances Skin Tumor Growth. Neoplasia. 2012 Apr;14(4):271-82.   PMCID: PMC3349254
Podolsky MA, Solomos AC, Durso LC, Evans SM, Rall GF, Rose RW. Extended JAK activation and delayed STAT1 dephosphorylation contribute to the distinct signaling profile of CNS neurons exposed to interferon-gamma. Journal of neuroimmunology. 2012 Oct;251(1-2):33-8.   PMCID: PMC 3678282
Rao SY, Lee SY, Gutierrez A, Perrigoue J, Thapa RJ, Tu ZG, Jeffers JR, Rhodes M, Anderson S, Oravecz T, Hunger SP, Timakhov RA, Zhang RG, Balachandran S, Zambetti GP, Testa JR, Look AT, Wiest DL. Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B. Blood. 2012 Nov;120(18):3764-73.   PMCID: PMC3488889
Rizzolio F, Lucchetti C, Caligiuri I, Marchesi I, Caputo M, Klein-Szanto A, Bagella L, Castronovo M, Giordano A. Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1. Cell death and differentiation. 2012 Jul;19(7):1152-61.   PMCID: PMC3374078
Evans JD, Crown RA, Sohn JA, Seeger C. West Nile Virus Infection Induces Depletion of IFNAR1 Protein Levels. Viral Immunol. 2011 Aug;24(4):253-63.   PMCID: PMC3154464
Katz RA, Merkel G, Andrake MD, Roder H, Skalka AM. Retroviral Integrases Promote Fraying of Viral DNA Ends. Journal of Biological Chemistry. 2011 Jul;286(29):25710-8.   PMCID: PMC3138259
Makhlin I, Zhang J, Long CJ, Devarajan K, Zhou Y, Klein-Szanto AJ, Huang M, Chernoff J, Boorjian SA. The mTOR pathway affects proliferation and chemosensitivity of urothelial carcinoma cells and is upregulated in a subset of human bladder cancers. BJU international. 2011 Jul;108(2B):E84-E90.   PMCID: PMC3116980
Makhov P, Kutikov A, Golovine K, Uzzo RG, Canter DJ, Kolenko VM. Docetaxel-Mediated Apoptosis in Myeloid Progenitor TF-I Cells Is Mitigated by Zinc: Potential Implication for Prostate Cancer Therapy. The Prostate. 2011 Sep;71(13):1413-9.   PMCID: PMC3106130
Tipton AR, Wang KX, Link L, Bellizzi JJ, Huang HM, Yen T, Liu ST. BUBR1 and Closed MAD2 (C-MAD2) Interact Directly to Assemble a Functional Mitotic Checkpoint Complex. Journal of Biological Chemistry. 2011 Jun;286(24):21173-9.   PMCID: PMC3122179
Balaburski GM, Hontz RD, Murphy ME. p53 and ARF: unexpected players in autophagy. Trends in Cell Biology. 2010 Jun;20(6):363-9.   PMCID: PMC2891045 [Available on 2011/6/1]
Mabuchi S, Kawase C, Altomare DA, Morishige K, Hayashi M, Sawada K, Ito K, Terai Y, Nishio Y, Klein-Szanto AJ, Burger RA, Ohmichi M, Testa JR, Kimura T. Vascular Endothelial Growth Factor Is a Promising Therapeutic Target for the Treatment of Clear Cell Carcinoma of the Ovary. Molecular Cancer Therapeutics. 2010 Aug;9(8):2411-22.   PMCID: PMC2941981 [Available on 2011/8/1]
Maguire S, Dobrzynski E, Alpaugh RK. Modified Skin-Window Technique in Cynomolgus Macaques (Macaca fasicularis) for Assessing Neutrophil Extravasation. Journal of the American Association for Laboratory Animal Science. 2010 Jul;49(4):475-9.   PMCID: PMCID: PMC2919190
Shanmugam D, Wu B, Ramirez U, Jaffe EK, Roos DS. Plastid-associated Porphobilinogen Synthase from Toxoplasma gondii KINETIC AND STRUCTURAL PROPERTIES VALIDATE THERAPEUTIC POTENTIAL. Journal of Biological Chemistry. 2010 Jul;285(29):22122-31.   PMCID: PMCID: PMC2903393 [Available on 2011/7/16]
Tan YF, Cheung M, Pei JM, Menges CW, Godwin AK, Testa JR. Upregulation of DLX5 Promotes Ovarian Cancer Cell Proliferation by Enhancing IRS-2-AKT Signaling. Cancer Research. 2010 Nov;70(22):9197-206.   PMCID: PMCID: PMC3018149 [Available on 2011/11/1]
Lewis-Wambi JS, Swaby R, Kim H, Jordan VC. Potential of L-buthionine sulfoximine to enhance the apoptotic action of estradiol to reverse acquired antihormonal resistance in metastatic breast cancer. Journal of Steroid Biochemistry and Molecular Biology. 2009 Mar;114(1-2):33-9.   PMCID: PMC28689080
Akagi R, Kato N, Lnoue R, Anderson KE, Jaffe EK, Sassa S. delta-Aminolevulinate dehydratase (ALAD) porphyria: The first case in North America with two novel ALAD mutations. Molecular genetics and metabolism. 2006 Apr;87(4):329-36.
Cianfrocca ME, Kimmel KA, Gallo J, Cardoso T, Brown MM, Hudes G, Lewis N, Weiner L, Lam GN, Brown SC, Shaw DE, Mazar AP, Cohen RB. Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2), a beta integrin antagonist, in patients with solid tumours. BRITISH JOURNAL OF CANCER. 2006 Jun;94(11):1621-6.
Heinrich MC, Corless CL, Blanke CD, Demetri GD, Joensuu H, Roberts PJ, Eisenberg BL, von Mehren M, Fletcher CD, Sandau K, McDougall K, Ou WB, Chen CJ, Fletcher JA. Molecular correlates of imatinib resistance in gastrointestinal stromal tumors. JOURNAL OF CLINICAL ONCOLOGY. 2006 Oct;24(29):4764-74.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term inhibition

inhibition cancer activation gene in-vitro expression apoptosis patient acid dehydratase gene-expression breast-cancer tumorigenesis angiogenesis phase-i protein in-vivo Oncology tyrosine kinase malignant-melanoma acute lymphoblastic-leukemia dengue virus proliferation alpha(v)beta(3) tyk2 concerted Cholangiocarcinoma Low dose estrogen therapy Antihormone resistance-Apoptosis-Breast cancer-L-Buthionine sulfoximine-Glutathione assemblies endoplasmic-reticulum stress malarial deregulation biology p31(comet) missense mutation cells substrate recognition interferon-alpha receptor crohns-disease therapeutic strategy transcription endothelial-growth-factor RATES gene family tamoxifen antitumor-activity apc homeobox gene-expression phase-ii clinical-trial melphalan growth Cancer stem cell DIAGNOSED MULTIPLE-MYELOMA marker molecular-mechanisms cyto-toxicity roles porphobilinogen-synthase target protection uptake psoriasis matrix-metalloproteinase sindbis virus-infection enzyme brain dermal inflammation spindle checkpoint radical cystectomy CNS neurons Interferon-gamma-Signal transduction-JAK-STAT strand transfer Inflammatory breast cancer rheumatoid-arthritis c-myc SINGLE-AGENT cell-cycle arrest GEMCITABINE retinoic acid encephalitis transporter factor-kappa-b mesylate alpha 5 beta 1 integrin ATN-161-alpha v beta 3 integrin-phase 1 trial-angiogenesis model sequence SURVIVAL rapamycin parasite heme-biosynthesis protein bubr1 HUMAN CHOLANGIOCARCINOMA CELLS EZH2 human head conformational dimerization chemotaxis pseudomonas-aeruginosa identification lymphoma signal-transduction pathway Bortezomib golgi network pp2a mouse skin noncytolytic clearance transformation cancer-cells plasmodium-falciparum epithelial-cells sarcoma virus integrase kit mutations mammalian target KAPPA-B tumor subtypes formation estrogen deprivation bladder cancer anaphase-promoting complex mouse model tissues leukocyte accumulation deficiency chemotherapy vitro growth-factor Proteosome induced apoptosis cdc20 therapy t-cell development biosynthesis factor-i receptor p53 modulation PLUS DEXAMETHASONE 5-aminolevulinate dehydratase cell-death INTRAHEPATIC CHOLANGIOCARCINOMA Tumor spheroid integration Pin1 pRb phosphorylation-CDK-cell cycle control mitochondrial p-32 acquired-resistance HISTOLOGIC TYPES translational control GALLBLADDER CARCINOMA ca dinucleotide isolated rat hepatocytes checkpoint-deficient bevacizumab
Last updated on Friday, July 10, 2020